Enovix (ENVX) had the lowest return in January 2023 by a US stock with a market cap of $2B+, returning -38%.
| ASSET | MONTH | % RETURN |
|---|---|---|
Enovix (ENVX) | January 2023 | -38.02% |
Immunitybio (IBRX) | January 2023 | -26.64% |
Calix (CALX) | January 2023 | -24.24% |
United States Antimony (UAMY) | January 2023 | -19.03% |
Summit Therapeutics (SMMT) | January 2023 | -18.2% |
Northrop Grumman (NOC) | January 2023 | -17.78% |
Enphase Energy (ENPH) | January 2023 | -17.75% |
Catalyst Pharmaceuticals (CPRX) | January 2023 | -17.17% |
D-Wave Quantum (QBTS) | January 2023 | -16.67% |
Verona Pharma PLC ADR (VRNA) | January 2023 | -16.64% |
Trustmark (TRMK) | January 2023 | -16.44% |
Molson Coors Beverage (TAP.A) | January 2023 | -14.94% |
Arrowhead Pharmaceuticals (ARWR) | January 2023 | -14.24% |
Pagaya Technologies (PGY) | January 2023 | -13.71% |
Texas Pacific Land Trust (TPL) | January 2023 | -13.49% |
Super Micro Computer (SMCI) | January 2023 | -12.94% |
Pfizer (PFE) | January 2023 | -12.63% |
Nextera Energy (NEE) | January 2023 | -11.54% |
Scorpio Tankers (STNG) | January 2023 | -11.14% |
Archer-Daniels-Midland (ADM) | January 2023 | -10.67% |
Avista (AVA) | January 2023 | -10.46% |
Park National (PRK) | January 2023 | -10.37% |
McCormick (MKC) | January 2023 | -9.76% |
Akero Therapeutics (AKRO) | January 2023 | -9.67% |
NBT Bancorp (NBTB) | January 2023 | -9.63% |
